Atul Pande Insider Trading $AXON Sio Gene Therapies Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Atul Pande.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Atul Pande. Atul Pande is Director in Axovant Sciences Ltd. ($AXON) and Director in Health Sciences Acquisitions Corp ($HSAC) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX).
Atul Pande in Sio Gene Therapies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Atul Pande: Director
Holdings: 33,370 shares
Current Value: $432,809
Latest Transaction: Apr 19 2021
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Atul Pande in Sio Gene Therapies Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IMVT, KRTX, AXON
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | AXON | Sio Gene Therapies ... | Pande Atul | Director | Option Exercise | A | 2.47 | 42,000 | 103,740 | 42,000 | |
| Nov 25 2020 | AXON | Sio Gene Therapies ... | Pande Atul | Director | Buy | P | 2.34 | 10,000 | 23,399 | 33,370 | 23.4 K to 33.4 K (+42.79 %) |
| Jul 10 2020 | AXON | Axovant Gene Thera ... | Pande Atul | Director | Buy | P | 2.73 | 10,000 | 27,290 | 23,370 | 13.4 K to 23.4 K (+74.79 %) |
| Apr 17 2020 | AXON | Axovant Gene Thera ... | Pande Atul | Director | Option Exercise | A | 3.45 | 17,500 | 60,375 | 17,500 | |
| Mar 18 2020 | AXON | Axovant Gene Thera ... | Pande Atul | Director | Buy | P | 1.78 | 10,000 | 17,844 | 13,370 | 3.4 K to 13.4 K (+296.74 %) |
| Jun 17 2019 | AXON | Axovant Gene Thera ... | Pande Atul | Director | Buy | P | 5.22 | 3,370 | 17,595 | 3,370 | 0 to 3.4 K |
| Apr 17 2019 | AXON | Axovant Sciences L ... | Pande Atul | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
| Mar 16 2018 | AXON | Axovant Sciences L ... | Pande Atul | Director | Option Exercise | A | 1.46 | 75,000 | 109,500 | 75,000 | |
| May 02 2017 | AXON | Axovant Sciences L ... | Pande Atul | Director | Option Exercise | A | 24.24 | 27,000 | 654,480 | 27,000 | |
| May 03 2016 | AXON | Axovant Sciences L ... | Pande Atul | Director | Option Exercise | A | 13.00 | 47,000 | 611,000 | 47,000 |
Page: 1